Inhibrx Biosciences Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| MORGAN STANLEY | 08/13/2026 | 1.31 M | $123.94 M | 3.56% | 8.39% |
| PERCEPTIVE ADVISORS LLC | 08/14/2026 | 1.30 M | $122.96 M | -10.05% | 8.33% |
| SANOFI | 07/28/2026 | 1.16 M | $109.71 M | 0.00% | 7.43% |
| VIKING GLOBAL INVESTORS LP | 08/14/2026 | 1.12 M | $106.49 M | -21.82% | 7.21% |
| HIGHTOWER ADVISORS, LLC | 08/05/2026 | 870.55 K | $82.48 M | 0.04% | 5.59% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 841.14 K | $79.70 M | 2,473.63% | 5.40% |
| BLACKROCK, INC. | 08/07/2026 | 825.97 K | $78.26 M | 3.39% | 5.30% |
| SCHONFELD STRATEGIC ADVISORS LLC | 08/14/2026 | 697.59 K | $66.10 M | 173.75% | 4.48% |
| STATE STREET CORP | 08/07/2026 | 640.46 K | $60.68 M | 16.27% | 4.11% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 492.48 K | $46.66 M | 1.24% | 3.16% |
| WOODLINE PARTNERS LP | 08/14/2026 | 400.89 K | $37.98 M | 4.28% | 2.57% |
| CAPITAL RESEARCH GLOBAL INVESTORS | 08/12/2026 | 363.05 K | $34.40 M | -7.58% | 2.33% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 338.18 K | $32.04 M | 255.70% | 2.17% |
| PFM HEALTH SCIENCES, LP | 08/14/2026 | 308.39 K | $29.22 M | 0.97% | 1.98% |
| SOFINNOVA INVESTMENTS, INC. | 08/14/2026 | 303.10 K | $28.72 M | -25.35% | 1.94% |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 08/13/2026 | 271.70 K | $25.74 M | 59.17% | 1.74% |
| PARKMAN HEALTHCARE PARTNERS LLC | 08/14/2026 | 256.95 K | $24.35 M | 100.00% | 1.65% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 256.18 K | $24.28 M | 10.65% | 1.64% |
| FIRST TURN MANAGEMENT, LLC | 08/14/2026 | 164.78 K | $15.61 M | 100.00% | 1.06% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 147.20 K | $13.95 M | -55.10% | 0.94% |
| CDC FINANCIAL, INC. | 08/14/2026 | 140.13 K | $13.28 M | 12.53% | 0.90% |
| FIRST TRUST ADVISORS LP | 08/11/2026 | 128.42 K | $12.17 M | 100.00% | 0.82% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 122.56 K | $11.61 M | 69.14% | 0.79% |
| CAPITOLIS LIQUID GLOBAL MARKETS LLC | 08/13/2026 | 119.20 K | $11.29 M | -4.64% | 0.76% |
| NORTHERN TRUST CORP | 08/13/2026 | 100.96 K | $9.57 M | 7.75% | 0.65% |
| NORGES BANK | 08/12/2026 | 90.30 K | $8.56 M | 100.00% | 0.58% |
| CITIGROUP INC | 08/03/2026 | 75.72 K | $7.17 M | 21.12% | 0.49% |
| JEFFERIES FINANCIAL GROUP INC. | 08/17/2026 | 73.42 K | $6.96 M | 88.38% | 0.47% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 72.20 K | $6.84 M | 36.74% | 0.46% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 69.92 K | $6.62 M | 8.70% | 0.45% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 66.50 K | $6.30 M | 0.00% | 0.43% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2026 | 62.20 K | $5.89 M | 23.95% | 0.40% |
| EVENTIDE ASSET MANAGEMENT, LLC | 08/14/2026 | 61.55 K | $5.83 M | 100.00% | 0.39% |
| BNP PARIBAS ARBITRAGE, SNC | 08/13/2026 | 59.84 K | $5.67 M | 83.91% | 0.38% |
| VOLEON CAPITAL MANAGEMENT LP | 08/14/2026 | 58.36 K | $5.53 M | 48.47% | 0.37% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 08/14/2026 | 48.77 K | $4.62 M | 261.20% | 0.31% |
| WESTERN STANDARD LLC | 08/10/2026 | 47.00 K | $4.45 M | 100.00% | 0.30% |
| NOMURA HOLDINGS INC | 08/14/2026 | 40.50 K | $3.84 M | 161.29% | 0.26% |
| CAPTION MANAGEMENT, LLC | 08/14/2026 | 40.40 K | $3.83 M | 143.37% | 0.26% |
| CITADEL ADVISORS LLC | 08/14/2026 | 37.30 K | $3.53 M | 8.43% | 0.24% |
| VICTORY CAPITAL MANAGEMENT INC | 08/07/2026 | 36.44 K | $3.45 M | 233.60% | 0.23% |
| ARROWMARK COLORADO HOLDINGS LLC | 08/13/2026 | 35.18 K | $3.33 M | 0.00% | 0.23% |
| UBS GROUP AG | 08/13/2026 | 35.02 K | $3.32 M | -27.25% | 0.22% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 08/03/2026 | 31.50 K | $2.98 M | 100.00% | 0.20% |
| EMPYREAN CAPITAL PARTNERS, LP | 08/14/2026 | 30.00 K | $2.84 M | 100.00% | 0.19% |
| CDC FINANCIAL, INC. | 08/14/2026 | 30.00 K | $2.84 M | -51.61% | 0.19% |
| ATOM INVESTORS LP | 08/14/2026 | 29.59 K | $2.80 M | 11.65% | 0.19% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 28.68 K | $2.72 M | 11.71% | 0.18% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 28.68 K | $2.72 M | 100.00% | 0.18% |
| CI PRIVATE WEALTH, LLC | 08/17/2026 | 28.65 K | $2.71 M | -0.56% | 0.18% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Inhibrx Biosciences Inc. institutional Ownership - FAQ's
During the previous two years, 205 institutional investors and hedge funds held shares of Inhibrx Biosciences Inc.. The most heavily invested institutionals were:
MORGAN STANLEY: 1.31 M
PERCEPTIVE ADVISORS LLC: 1.3 M
Sanofi: 1.16 M
VIKING GLOBAL INVESTORS LP: 1.12 M
HighTower Advisors, LLC: 870,551
BANK OF AMERICA CORP /DE/: 841,141
92.09% of Inhibrx Biosciences Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 15.92 M shares in the last 24 months. This purchase volume represents approximately $1.14 B in transactions.